Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
7 studies found for:    Bronchiectasis | Open Studies | NIH, U.S. Fed
Show Display Options
RSS Create an RSS feed from your search for:
Bronchiectasis | Open Studies | NIH, U.S. Fed
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Cross-sectional Characterization of Idiopathic Bronchiectasis
Condition: Infection
2 Recruiting Natural History of Bronchiectasis
Conditions: Bronchiectasis;   Cystic Fibrosis;   Autoimmune Disease;   Common Variable Immunodeficiency
3 Unknown  A Safety Trial of DAS181 (Fludase®) in Adult Subjects With Well-Controlled Asthma or Bronchiectasis
Conditions: Asthma;   Bronchiectasis
Interventions: Drug: DAS181 dry powder, formulation F02;   Drug: Respitose ML006 (DMV-Fonterra)
4 Recruiting Studying Patients With Cystic Fibrosis and Other Pulmonary and Pancreatic Disorders
Condition: Cystic Fibrosis
5 Recruiting Study of Clinical Features and Genetics of Hyperimmunoglobulin E Recurrent Infection
Condition: Job's Syndrome
6 Recruiting Genetics of Primary Ciliary Dyskinesia
Conditions: Primary Ciliary Dyskinesia;   Kartagener Syndrome
7 Recruiting Pathogenesis of Primary Ciliary Dyskinesia (PCD) Lung Disease
Condition: Kartagener Syndrome

Indicates status has not been verified in more than two years